| Abstract O24 – Table 1. Baseline patient characteristics. | |||
|---|---|---|---|
| Characteristic | Group A (n = 126) | Group B (n = 132) | p‐valuea |
| Age (year), IQR | 29 (25.0 to 35.0) | 29 (25.0 to 38.3) | 0.488 |
| Race (Han), n (%) | 109 (96.5) | 110 (90.2) | 0.056 |
| BMI (kg/m2), IQR | 23.2 (20.2 to 25.3) | 22.9 (20.3 to 24.8) | 0.552 |
| Number of comorbidities >0, n (%) | 11 (18.3) | 12 (18.7) | 0.952 |
| Number of medications >0, n (%) | 10 (16.7) | 12 (18.7) | 0.762 |
| HBs antigen positive, n (%) | 7 (6.3) | 6 (5.0) | 0.679 |
| HCV antibody positive, n (%) | 1 (0.9) | 1 (0.8) | 0.966 |
| RPR positive, n (%) | 22 (22.4) | 31 (30.7) | 0.188 |
| Baseline viral load (lg copies/mL), IQR | 4.4 (4.0 to 4.8) | 4.3 (3.8 to 5.0) | 0.444 |
| Viral load >100 000 (copies/mL), n (%) | 19 (18.4) | 27 (25.0) | 0.249 |
| Baseline CD4 count (cells/μL), IQR | 342 (243.0 to 448.6) | 342 (241.0 to 449.6) | 0.913 |
| Baseline CD4 count <200 cells/uL, n (%) | 22 (17.9) | 22 (17.3) | 0.907 |
| CD4/CD8, IQR | 0.3 (0.2 to 0.5) | 0.4 (0.2 to 0.5) | 0.779 |
| Time from diagnosis to treatment (day), IQR | 6 (3.0 to 8.0) | 5 (2.0 to 7.0) | 0.064 |
aContinuous and categorical variables were compared by the Mann‐Whitney U test and the chi‐square test, respectively.